- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02021799
The Effect of Under-nutrition on the Human Microbiota
December 19, 2013 updated by: Dr. Gregor Reid, Western University, Canada
The Effect of Nutrition on the Microbiome in Pregnant Women and the Use of Micronutrient Supplemented Probiotic Yogurt to Improve Outcomes
The purpose of this study is to determine whether a difference exists in the gut, oral, vaginal and human milk microbiome of under-nourished pregnant women as compared to healthy and obese pregnant women.
In addition, the investigators are setting out to determine if a micronutrient enriched probiotic yogurt can improve the microbiome and pregnancy outcomes of under-nourished pregnant women.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
77
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buswelu, Tanzania
- Nyerere Dispensary
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Greater than 12 weeks pregnant
- between the ages of 18 and 40 years
Exclusion Criteria:
- Less than 12 weeks pregnant
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
NO_INTERVENTION: Undernourished Pregnant Women
Pregnant women who are classified as undernourished
|
|
NO_INTERVENTION: Nourished Pregnant Women
Pregnant women who are classified as healthy
|
|
NO_INTERVENTION: Overweight/obese Pregnant women
Pregnant women who are classified as obese or overweight
|
|
EXPERIMENTAL: Undernourished + Yogurt Pregnant Women
Pregnant women who are undernourished and selected to receive Moringa and Lactobacillus rhamnosus GR-1 probiotic yogurt.
Yogurt contained 4.3 grams of Moringa and 10^8 CFU/mL of Lactobacillus rhamnosus GR-1 as well as Streptococcus thermophilus and Lactobacillus bulgaricus starter cultures.
|
|
EXPERIMENTAL: Nourished + Yogurt Pregnant Women
Pregnant women who are healthy and selected to receive Moringa and Lactobacillus rhamnosus GR-1 probiotic yogurt.
Yogurt contained 4.3 grams of Moringa and 10^8 CFU/mL of Lactobacillus rhamnosus GR-1 as well as Streptococcus thermophilus and Lactobacillus bulgaricus starter cultures.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Characterization of gut, oral, vaginal and human milk microbiomes
Time Frame: Monthly for an average of four months
|
Fecal, oral and vaginal samples were collected on a monthly basis for an average of four months.
Human milk samples were collected twice; at birth and one week after.
Microbial DNA will be extracted with the MoBio PowerSoil 96-well htp kit.
Samples will be sequenced and changes determined by 16s rRNA profiling.
|
Monthly for an average of four months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of 48-hour Dietary Recalls
Time Frame: Monthly on average for four months
|
Dietary recalls will be assessed for average daily caloric, protein, carbohydrate, fat, calcium, iron, zinc, folate and vitamin intake using ESHA Food Processor SQL software.
|
Monthly on average for four months
|
Changes in body toxin levels
Time Frame: Before and after intervention (approximately 100 days)
|
Body toxin levels (metals, pesticides) by HR-SF-ICP-MS and GC/MS
|
Before and after intervention (approximately 100 days)
|
Changes in blood nutrient levels
Time Frame: before, half-way through and after intervention (approximately 100 days)
|
Blood nutrient levels (vitamins, macro and micr-nutrients) will be assessed by HPLC, colorimetric Biuret, chemiluminescence and HR-SF-ICP-MS
|
before, half-way through and after intervention (approximately 100 days)
|
Analysis of anthropometric measurements
Time Frame: Monthly on average for four months
|
Changes in weight gain, mid-upper arm circumference and hemoglobin levels will be examined and changes will be linked to intervention and non-intervention via statistical analysis.
|
Monthly on average for four months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Analysis of Anthropometric Measurements
Time Frame: Monthly on Average for 4 months
|
Change in the weight gain, mid-upper arm circumference and hemoglobin measurements will be analyzed over the course of study.
|
Monthly on Average for 4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Gregor Reid, BSc Hons PhD MBA ARM CCM Dr HS, Western University, Canada; Lawson Health Research Institute
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2012
Primary Completion (ACTUAL)
April 1, 2013
Study Completion (ACTUAL)
April 1, 2013
Study Registration Dates
First Submitted
July 4, 2013
First Submitted That Met QC Criteria
December 19, 2013
First Posted (ESTIMATE)
December 27, 2013
Study Record Updates
Last Update Posted (ESTIMATE)
December 27, 2013
Last Update Submitted That Met QC Criteria
December 19, 2013
Last Verified
December 1, 2013
More Information
Terms related to this study
Other Study ID Numbers
- 102400
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier René DubosCompletedDeciduitis; Complicating Pregnancy
Clinical Trials on Moringa and Lactobacillus rhamnosus GR-1
-
Azienda Ospedaliero, Universitaria PisanaCompleted
-
Baylor College of MedicineLawson Health Research Institute; Chr HansenUnknown
-
Western University, CanadaNational Institute for Medical Research, TanzaniaCompleted
-
National Institute for Medical Research, TanzaniaErasmus Medical Center; Lawson Health Research Institute; University of Western... and other collaboratorsUnknownHIV Infections | Diarrhea | Bacterial VaginosisTanzania
-
Baylor College of MedicineShriners Hospitals for ChildrenWithdrawn
-
Lawson Health Research InstituteUniversity of Western Ontario, Canada; St. Joseph's Health Care LondonCompleted
-
Duke UniversityCompletedMicrobiomeUnited States
-
Peking University Shenzhen HospitalBGI, ChinaCompleted
-
Western University, CanadaCompletedBacterial Vaginosis | Vulvovaginal CandidiasisRwanda
-
Valio LtdUniversity of Virginia; University of Helsinki; Medcare LtdCompletedRespiratory Tract Infections [C08.730]United States